Jeff Deneen, Ph.D.
SANTA CLARA, Calif.—August 5, 2010—Atypon™, a leading provider of software to the publishing and media industry, today announced that Informa Healthcare, one of the world's leading medical and scientific publishers, is now publishing books on the redesigned informahealthcare.com platform.
Informa Healthcare, which is a division of Informa plc (LSE: INF), publishes authoritative research and analysis as well as up-to-date news for all sectors of the healthcare and life sciences community. The informahealthcare.com platform is powered by Atypon's Literatum™ software.
Informa Healthcare decided to add more than 600 book titles to the 170 journals on informahealthcare.com to allow users to search across content type to easily obtain critical research. Expanding their use of Literatum, which supports multiple content types on one platform, was a natural decision.
"Partnering with Atypon to deliver a single publishing platform for both books and journals allows us to better serve our community," said Phil Garner, Divisional Managing Director of Informa Healthcare. "We now provide this even more comprehensive resource to our users—saving them valuable research time—while having the utmost flexibility in managing and delivering content across our portfolio."
Atypon is setting new standards for digital content delivery, discovery, and monetization. The company's solutions include Literatum™, the leading platform for professional and scholarly publishers, and RightSuite™, an enterprise access and commerce platform for publishing and media organizations. For more information, visit www.Atypon.com.
Informa Healthcare provides authoritative research and analysis for all sectors of the Life Science, Medicine and Pharmaceutical sectors to better serve the commercial and academic needs within the scientific and clinical communities. Informa Healthcare is a division of Informa plc (London: INF). Informa has more than 150 offices in 40 countries and employs 7,500 staff around the world. Informa Healthcare is headquartered in London with offices in New York, Melbourne, Singapore and Stockholm.